Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that might suggest mechanisms to prevent and manage it.


Clinical Trial Description

Patient will be recruited from those admitted to our Labor and Delivery unit. Ten women will be the control subjects, and these will be selected from patients who are admitted for scheduled cesarean delivery. Ten women will be selected from women who develop uterine atony either following cesarean delivery, or postpartum patients who delivered vaginally but subsequently required surgical management of uterine atony (hysterectomy or uterine saving surgery). From each patient a small amount of uterine muscle will be excised and placed in a fixative, preservative transport medium. Ten cubic centimeters of blood will be drawn from each patient to accompany the tissue. The tissue and blood will be processed and analyzed to identify differences in the tissue and plasma of messenger RNA, micro RNA, long non-coding RNA, and DNA methylation in normal and atonic uterine patients. Statistical analysis of these markers will be performed to determine whether there are significant differences in their expression. It is hoped that differences will be discovered that may be used diagnostically to predict uterine atony, and differences that may suggest the etiology of uterine atony. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03413917
Study type Observational
Source Baylor Research Institute
Contact Jack Stecher, MD
Phone 214-820-2126
Email jackstecher@sbcglobal.net
Status Recruiting
Phase
Start date February 2, 2018
Completion date January 15, 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02910115 - Cooling the Uterus in C-section After Dysfunctional Labor N/A
Withdrawn NCT02410655 - An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery Phase 4
Completed NCT00790062 - Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Phase 4
Recruiting NCT01579201 - ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery Phase 4
Completed NCT03867383 - Calcium Chloride for Prevention of Uterine Atony During Cesarean Phase 1/Phase 2
Active, not recruiting NCT03584854 - Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial Phase 4
Completed NCT02780245 - Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section Phase 4
Completed NCT00785395 - Up-Down Oxytocin Infusion Phase 4
Withdrawn NCT03303235 - Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections Early Phase 1
Completed NCT02229513 - Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage N/A
Not yet recruiting NCT06192836 - Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
Withdrawn NCT01252342 - Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? Phase 4
Completed NCT04690153 - Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
Completed NCT05027048 - Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery Phase 3
Completed NCT01630187 - Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section Phase 4
Completed NCT01549223 - Oxytocin And Uterotonic Agent Use For Cesarean Delivery Phase 4